Yew Bio-Pharm Group Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,899.70
4,284.20
5,284.60
2,006.90
3,213.00
1,322.40
Depreciation, Depletion & Amortization
561.50
682.80
7,742.50
8,931.30
67.80
75
Other Funds
0.20
2,330.80
749.20
48.90
-
20,892.20
Funds from Operations
4,461.60
5,470.40
14,060.70
13,469.20
7,669.20
19,644.70
Changes in Working Capital
18.80
1,355.10
16,066.80
13,441.60
9,078.60
12,822.20
Net Operating Cash Flow
4,442.80
4,115.40
2,006.10
27.60
1,409.40
32,467
Capital Expenditures
3,692.70
2,452.70
2,049.50
61.50
799.10
Sale of Fixed Assets & Businesses
-
5.00
3.60
-
-
Net Investing Cash Flow
3,692.70
2,447.70
2,362.80
234.90
799.10
Issuance/Reduction of Debt, Net
-
-
3,850.40
597.50
2,713.90
Net Financing Cash Flow
0.20
2,330.80
4,599.60
646.40
2,713.90
Net Change in Cash
772.80
671.70
193.70
402.60
580.80
Free Cash Flow
4,143.20
4,106.80
2,037.60
33.90
1,409.40
Other Sources
-
-
35.40
296.40
-
Exchange Rate Effect
22.90
8.50
37.10
18.70
75.50
Other Uses
-
-
352.20
-
-
About Yew Bio-Pharm Group
View Profile
